483 Spark Therapeutics Aug 2017

483 Spark Therapeutics Aug 2017

Rabia Ballica FDA$119.00 - Available Now

FDA investigators audited the Spark Therapeutics - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 25 Aug 2017.

Product details

  • Category: Biologics
  • Inspection end: 25 Aug 2017
  • Location: Philadelphia, United States
  • FEI: 3011194531
Add To Cart